Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Pharmacogenetic Impact of VKORC1 and CYP2C9 allelic variants on warfarin dose requirements in a hispanic population isolate

Simple item page
dc.contributor.authorPalacio, L. G.
dc.contributor.authorFalla, D.
dc.contributor.authorTobon, I.
dc.contributor.authorMejia, F.
dc.contributor.authorLewis, J. E.
dc.contributor.authorMartinez, A. F.
dc.contributor.authorArcos-Burgos, Mauricio
dc.contributor.authorCamargo, Mauricio
dc.date.accessioned2015-12-13T22:43:13Z
dc.date.issued2010
dc.date.updated2016-02-24T09:36:11Z
dc.description.abstractWarfarin is the most prescribed oral anticoagulant worldwide. Because of the complexity of warfarin therapy, we attempted to dissect genetic from bioenvironmental factors influencing warfarin dose responses in individuals of a genetic isolate of Hispanic
dc.identifier.issn1076-0296
dc.identifier.urihttp://hdl.handle.net/1885/79098
dc.publisherSAGE Publications
dc.sourceClinical and Applied Thrombosis/Hemostasis
dc.subjectKeywords: warfarin; adult; age; allele; artery thrombosis; article; controlled study; CYP2C9 gene; deep vein thrombosis; environmental factor; female; gene; gene interaction; genetic polymorphism; genetic variability; genotype; genotype environment interaction; His Colombia; CYP2C9; Genetic isolate; Pharmacogenetics; VKORC1; Warfarin
dc.titlePharmacogenetic Impact of VKORC1 and CYP2C9 allelic variants on warfarin dose requirements in a hispanic population isolate
dc.typeJournal article
local.bibliographicCitation.issue1
local.bibliographicCitation.lastpage90
local.bibliographicCitation.startpage83
local.contributor.affiliationPalacio, LG, University of Antioquia
local.contributor.affiliationFalla, D., Universidad de Antioquia
local.contributor.affiliationTobon, I, Hospital Universitario San Vicente de Paú L
local.contributor.affiliationMejia, F., Hospital Universitario San Vicente de Paú L
local.contributor.affiliationLewis, J.E., University of Miami
local.contributor.affiliationMartinez, A.F., University of Miami
local.contributor.affiliationArcos-Burgos, Mauricio (Oscar), College of Medicine, Biology and Environment, ANU
local.contributor.affiliationCamargo, Mauricio, University of Antioquia
local.contributor.authoruidArcos-Burgos, Mauricio (Oscar), u5088570
local.description.embargo2037-12-31
local.description.notesImported from ARIES
local.identifier.absfor060408 - Genomics
local.identifier.ariespublicationf5625xPUB7619
local.identifier.citationvolume16
local.identifier.doi10.1177/1076029608330472
local.identifier.scopusID2-s2.0-76049103379
local.type.statusPublished Version

Downloads

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
01_Palacio_Pharmacogenetic_Impact_of_2010.pdf
Size:
270.12 KB
Format:
Adobe Portable Document Format
Download

Collections

ANU Research Publications

DSpace software copyright © 2002-2026 LYRASIS